The Romanian Competition Authority rejects a complaint regarding on refusal to supply in the pharmaceutical sector (Roche)

On 19 May 2013, following the principles established by the European preliminary ruling in GlaxoSmithKline [1], the Romanian Competition Council (“RCC”) held that La Roche (“Roche”) did not abuse its dominant position on the pharmaceuticals distribution market [2]. On 24 September 2010, SC Relad International SRL (“Relad”) submitted a complaint to the RCC, alleging that Roche held a dominant position on the pharmaceuticals distribution market and, by constantly refusing to sell pharmaceutical products and applying a discriminatory supply policy, Roche abused its dominant position. According to Relad, the potential abuse consisted of: • the limitation and control of distribution to the disadvantage of consumers, and restriction on exports in the European Union; • the discrimination

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Nestor Nestor Diculescu Kingston Petersen (Bucharest)
  • Nestor Nestor Diculescu Kingston Petersen (Bucharest)

Quotation

Georgeta Dinu, Adelina Roman, The Romanian Competition Authority rejects a complaint regarding on refusal to supply in the pharmaceutical sector (Roche), 8 May 2013, e-Competitions Bulletin Competition in the Pharmaceutical sector, Art. N° 64976

Visites 189

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues